AAX Biotech

Stockholm, Sweden · Founded 2020 · Privately Held (backing)

Developer of antibody technologies intended for cancer, autoimmune diseases, and neurological diseases. AAX Biotech is based in Stockholm, Sweden and was founded in 2020. Its last reported valuation was $4.1 million in Oct 2024. It has raised $1.2 million.

Last reported valuation
$4.1M
Oct 2026
Priced at
—
Total raised
$1.2M
Last round
—

Who backs AAX Biotech?

12 investors
InvestorType
Jinderman & Partners—
DRIVE ( KI Innovations Business Incubator)—
HJKK Didrikson—
Karolinska Institutet—
Karolinska Institutet Holding—
Life Science Invest—
Northislet—
Phase2Phase Biopharma—
Sciety—
SmiLe Incubator—
+ 2 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

AAX Biotech investors

12 investors are on record for AAX Biotech, including Jinderman & Partners, DRIVE ( KI Innovations Business Incubator), HJKK Didrikson and Karolinska Institutet.

Free account
More of AAX Biotech with a free account
  • ·The complete investor list: 12 names
  • ·Watch AAX Biotech: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 12 firms already write checks for companies like AAX Biotech. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View